Information about Allero Therapeutics
My details
*
*
*

Allero Therapeutics (SRL)

Company information

Status
Active

Enterprise number

BE0665.757.817

VAT liability
No
Established
04-11-2016
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Manufacture of medicaments
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Allero Therapeutics

2024 2023 2022 2021
Profit/Loss 123 101 % -11,756 -105 % 254,322 1857 % -14,471
Equity 71,539 0 % 71,416 -14 % 83,172 149 % -171,150
Gross margin -2,286 85 % -15,040 -106 % 249,450 4895 % 4,994

Publications from Allero Therapeutics

Date Publication
29-11-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Miscellaneous - Resignations - Appointments (NL)
07-09-2018 Capital - Shares (NL)
19-04-2018 Registered Office (NL)
08-11-2016 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the enterprise number of Allero Therapeutics?
The enterprise number of Allero Therapeutics is BE 0665.757.817.
Wat is the PEPPOL ID of Allero Therapeutics?
The PEPPOL ID of Allero Therapeutics is 0208:0665757817. Log in or start a free trial to see the full overview.
When was Allero Therapeutics founded?
Allero Therapeutics was founded on 04-11-2016.
What is the address of Allero Therapeutics?
The current registered office of Allero Therapeutics is located at Onderstraat 7/211, 9000 Gent.
When was the last time Allero Therapeutics filed their annual financial statements?
The most recent financial statements of Allero Therapeutics were filed on 05-07-2025.
How many employees does Allero Therapeutics have?
There are currently no employees working at Allero Therapeutics or no workforce information is available.
What is the annual turnover of Allero Therapeutics?
At the time of its most recent financial statements, Allero Therapeutics did not publish any turnover figures. Allero Therapeutics reported a gross margin of -€2,285.69.